Celldex Therapeutics Inc (CLDX) is traded on NASDAQ in USA. It is located in NEW JERSEY, U.S.A and employs 196 people. Celldex Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 385.03 M. Celldex Therapeutics Inc has 128.34 M outstanding shares of which 13.26 M shares are currently shorted by private and institutional investors with about 13.59 trading days to cover.
CELLDEX THERAPEUT currently holds about 153.98 M in cash with (100.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Check Celldex Therapeutics Probability Of Bankruptcy